Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Styliani Vlachou
WIN 55,212-2 Decreases the Reinforcing Actions of Cocaine Through CB1 Cannabinoid Receptor Stimulation
Behavioural Brain Research
Behavioral Neuroscience
Related publications
Effects of Glucagon-Like Peptide-1 Receptor Stimulation and Blockade on Food Consumption and Body Weight in Rats Treated With a Cannabinoid CB1 Receptor Agonist WIN 55,212-2
Medical science monitor basic research
Medicine
The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Cannabinoid Agonist WIN-55,212-2 Partially Restores Neurogenesis in the Aged Rat Brain
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
Involvement of the CB2 Cannabinoid Receptor in Cell Growth Inhibition and G0/G1 Cell Cycle Arrest via the Cannabinoid Agonist WIN 55,212–2 in Renal Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Gestational Exposure to the Cannabinoid WIN 55,212-2 and Its Effect on the Innate Intestinal Immune Response
Scientific Reports
Multidisciplinary
Activation of Mitogen-Activated Protein Kinases by Stimulation of the Central Cannabinoid Receptor CB1
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Direct Intra-Accumbal Infusion of a Beta-Adrenergic Receptor Antagonist Abolishes WIN 55,212-2-Induced Aversion
Neuroscience Letters
Neuroscience
Modulation of Mu-Opioid Receptor Signaling by Cannabinoid CB1 Receptor Through Heteromerization, a Novel Analgesic Target
Biophysical Journal
Biophysics
Cannabinoid WIN-55,212-2 Mesylate Inhibits ADAMTS-4 Activity in Human Osteoarthritic Articular Chondrocytes by Inhibiting Expression of Syndecan-1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
